Harriet Lane Handbook
Dolasetron
Anzemet
Antiemetic agent, 5-HT3 antagonist
| B | ? | Yes | Yes | No |
| Key |
- Tabs: 50 mg
- Oral suspension: 10 mg/mL
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Hughes, Helen K., and Lauren K. Kahl, editors. "Dolasetron." Harriet Lane Handbook Harriet Lane Handbook, 23rd ed., Elsevier, 2024. Harriet Lane, www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309388/all/Dolasetron.
Dolasetron. In: Hughes HKH, Kahl LKL, eds. Harriet Lane Handbook Harriet Lane Handbook. Elsevier; 2024. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309388/all/Dolasetron. Accessed September 29, 2026.
Dolasetron. (2024). In Hughes, H. K., & Kahl, L. K. (Eds.), Harriet Lane Handbook Harriet Lane Handbook (23rd ed.). Elsevier. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309388/all/Dolasetron
Dolasetron [Internet]. In: Hughes HKH, Kahl LKL, eds. Harriet Lane Handbook Harriet Lane Handbook. Elsevier; 2024. [cited 2026 September 29]. Available from: https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309388/all/Dolasetron.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dolasetron
ID - 309388
ED - Hughes,Helen K,
ED - Kahl,Lauren K,
BT - Harriet Lane Handbook
UR - https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309388/all/Dolasetron
PB - Elsevier
ET - 23
DB - Harriet Lane
DP - Unbound Medicine
ER -
